A Randomized Double-blind, Placebo-controlled Trial of Adipose-derived Regenerative Cells Injected into Corpora Cavernosum Following Radical Prostatectomy | Synapse
March 2, 2026Open Access
A Randomized Double-blind, Placebo-controlled Trial of Adipose-derived Regenerative Cells Injected into Corpora Cavernosum Following Radical Prostatectomy
Key Points
To evaluate the effects of injecting adipose-derived regenerative cells into the corpora cavernosa on erectile dysfunction following radical prostatectomy.
Conducted a randomized double-blind trial
Participants received either ADRCs or placebo injections
Evaluated erectile function using standardized measures
Injections of ADRCs were found to be safe with no serious complications reported.
No significant improvement in erectile dysfunction was observed in the treatment group compared to placebo.
Abstract
Intracavernous injections of ADRCs appear safe, but had no measurable effect on ED after RP and thus cannot be recommended in its current form.